Watch Demo

Radiotherapy Market Research Report by Product, Procedure, Application, End-User, Country - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - North America Forecast 2023-2030

Radiotherapy Market Research Report by Product, Procedure, Application, End-User, Country - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - North America Forecast 2023-2030
  • Publish Date:January 2023

  • Number of Pages:136

  • Report ID:6405716

  • Format:PDF

  • Publisher:360iResearch

$ 3949

Summary

Radiotherapy Market Research Report by Product (Conventional Cobalt-60 Teletherapy Units, Conventional Linear Accelerators, and Electron-Emitting High-Energy Linear Accelerators), Procedure, Application, End-User, Country - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - North America Forecast 2023-2030

The North America Radiotherapy Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the North America Radiotherapy Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the North America Radiotherapy Market.

Cumulative Impact of Russia-Ukraine Conflict:

We continuously monitor and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the North America Radiotherapy Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The North America Radiotherapy Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the North America Radiotherapy Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group’s economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players’ strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the North America Radiotherapy Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market is studied across Conventional Cobalt-60 Teletherapy Units, Conventional Linear Accelerators, Electron-Emitting High-Energy Linear Accelerators, External Beam Radiotherapy, Internal Beam Radiotherapy or Brachytherapy, Particle Therapy Systems, Stereotactic Advanced Electron or Cobalt-60 Linear Accelerators, and Systemic Radiotherapy. The Internal Beam Radiotherapy or Brachytherapy is further studied across Afterloaders, Applicators, and IORT Systems. The Particle Therapy Systems is further studied across Cyclotrons, Synchrocyclotron, and Synchrotrons. The Stereotactic Advanced Electron or Cobalt-60 Linear Accelerators is further studied across CyberKnife, Gamma Knife, and TomoTherapy. The Systemic Radiotherapy is further studied across Iobenguane (I-131), Rhenium-186, and Samarium-153.

Based on Procedure, the market is studied across External Beam Radiotherapy, Instillation Radiotherapy, Internal Beam Radiotherapy or Brachytherapy, Intravenous Radiotherapy, Oral Radiotherapy, and Systemic Radiotherapy. The External Beam Radiotherapy is further studied across 3D Conformal Radiotherapy, Image-Guided Radiotherapy, Intensity-Modulated Radiotherapy, Particle Therapy, and Stereotactic Therapy. The Internal Beam Radiotherapy or Brachytherapy is further studied across High-Dose-Rate Brachytherapy, Low-Dose-Rate Brachytherapy, and Pulsed-Dose-Rate Brachytherapy.

Based on Application, the market is studied across Breast Cancer, Cervical Cancer, Colorectal Cancer, Gynecological Cancer, Head & Neck Cancer, Lung Cancer, Penile Cancer, and Prostate Cancer.

Based on End-User, the market is studied across Hospitals and Independent Radiotherapy Centers.

Based on Country, the market is studied across Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the North America Radiotherapy Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The North America Radiotherapy Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The North America Radiotherapy Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The North America Radiotherapy Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the North America Radiotherapy Market, including Accuray Incorporated, Becton, Dickinson and Company, Elekta AB, General Electric Company, IBA Worldwide, IntraOp Medical, Inc., Koninklijke Philips N.V., Leo Cancer Care, Mevion Medical Systems, Panacea Medical Technologies Pvt. Ltd., Qfix, Radiology Oncology Systems, Varian Medical Systems, Inc., ViewRay Technologies, Inc., and ZEISS Group.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the North America Radiotherapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the North America Radiotherapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the North America Radiotherapy Market?
4. What is the competitive strategic window for opportunities in the North America Radiotherapy Market?
5. What are the technology trends and regulatory frameworks in the North America Radiotherapy Market?
6. What is the market share of the leading vendors in the North America Radiotherapy Market?
7. What modes and strategic moves are considered suitable for entering the North America Radiotherapy Market?

Table of contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Radiotherapy Market, by Product
6.1. Introduction
6.2. Conventional Cobalt-60 Teletherapy Units
6.3. Conventional Linear Accelerators
6.4. Electron-Emitting High-Energy Linear Accelerators
6.5. External Beam Radiotherapy
6.6. Internal Beam Radiotherapy or Brachytherapy
6.7.1. Afterloaders
6.7.2. Applicators
6.7.3. IORT Systems
6.7. Particle Therapy Systems
6.8.1. Cyclotrons
6.8.2. Synchrocyclotron
6.8.3. Synchrotrons
6.8. Stereotactic Advanced Electron or Cobalt-60 Linear Accelerators
6.9.1. CyberKnife
6.9.2. Gamma Knife
6.9.3. TomoTherapy
6.9. Systemic Radiotherapy
6.10.1. Iobenguane (I-131)
6.10.2. Rhenium-186
6.10.3. Samarium-153

7. Radiotherapy Market, by Procedure
7.1. Introduction
7.2. External Beam Radiotherapy
7.3.1. 3D Conformal Radiotherapy
7.3.2. Image-Guided Radiotherapy
7.3.3. Intensity-Modulated Radiotherapy
7.3.4. Particle Therapy
7.3.5. Stereotactic Therapy
7.3. Instillation Radiotherapy
7.4. Internal Beam Radiotherapy or Brachytherapy
7.5.1. High-Dose-Rate Brachytherapy
7.5.2. Low-Dose-Rate Brachytherapy
7.5.3. Pulsed-Dose-Rate Brachytherapy
7.5. Intravenous Radiotherapy
7.6. Oral Radiotherapy
7.7. Systemic Radiotherapy

8. Radiotherapy Market, by Application
8.1. Introduction
8.2. Breast Cancer
8.3. Cervical Cancer
8.4. Colorectal Cancer
8.5. Gynecological Cancer
8.6. Head & Neck Cancer
8.7. Lung Cancer
8.8. Penile Cancer
8.9. Prostate Cancer

9. Radiotherapy Market, by End-User
9.1. Introduction
9.2. Hospitals
9.3. Independent Radiotherapy Centers

10. Canada Radiotherapy Market
10.1. Introduction

11. Mexico Radiotherapy Market
11.1. Introduction

12. United States Radiotherapy Market
12.1. Introduction

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Product Portfolio Analysis, By Key Player
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Accuray Incorporated
14.2. Becton, Dickinson and Company
14.3. Elekta AB
14.4. General Electric Company
14.5. IBA Worldwide
14.6. IntraOp Medical, Inc.
14.7. Koninklijke Philips N.V.
14.8. Leo Cancer Care
14.9. Mevion Medical Systems
14.10. Panacea Medical Technologies Pvt. Ltd.
14.11. Qfix
14.12. Radiology Oncology Systems
14.13. Varian Medical Systems, Inc.
14.14. ViewRay Technologies, Inc.
14.15. ZEISS Group

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. NORTH AMERICA RADIOTHERAPY MARKET: RESEARCH PROCESS
FIGURE 2. NORTH AMERICA RADIOTHERAPY MARKET SIZE, 2022 VS 2030
FIGURE 3. NORTH AMERICA RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 5. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. NORTH AMERICA RADIOTHERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 7. NORTH AMERICA RADIOTHERAPY MARKET DYNAMICS
FIGURE 8. NORTH AMERICA RADIOTHERAPY MARKET PORTER'S FIVE FORCES ANALYSIS
FIGURE 9. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 10. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. NORTH AMERICA RADIOTHERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
FIGURE 12. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL COBALT-60 TELETHERAPY UNITS, 2018-2030 (USD MILLION)
FIGURE 13. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
FIGURE 14. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY ELECTRON-EMITTING HIGH-ENERGY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
FIGURE 15. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 16. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2030 (USD MILLION)
FIGURE 17. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
FIGURE 18. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY APPLICATORS, 2018-2030 (USD MILLION)
FIGURE 19. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY IORT SYSTEMS, 2018-2030 (USD MILLION)
FIGURE 20. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
FIGURE 21. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY CYCLOTRONS, 2018-2030 (USD MILLION)
FIGURE 22. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY SYNCHROCYCLOTRON, 2018-2030 (USD MILLION)
FIGURE 23. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY SYNCHROTRONS, 2018-2030 (USD MILLION)
FIGURE 24. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC ADVANCED ELECTRON OR COBALT-60 LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
FIGURE 25. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY CYBERKNIFE, 2018-2030 (USD MILLION)
FIGURE 26. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY GAMMA KNIFE, 2018-2030 (USD MILLION)
FIGURE 27. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY TOMOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 28. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 29. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY IOBENGUANE (I-131), 2018-2030 (USD MILLION)
FIGURE 30. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY RHENIUM-186, 2018-2030 (USD MILLION)
FIGURE 31. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY SAMARIUM-153, 2018-2030 (USD MILLION)
FIGURE 32. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2022 VS 2030 (%)
FIGURE 33. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 34. NORTH AMERICA RADIOTHERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY PROCEDURE, 2030
FIGURE 35. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 36. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY 3D CONFORMAL RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 37. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY IMAGE-GUIDED RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 38. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY INTENSITY-MODULATED RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 39. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY, 2018-2030 (USD MILLION)
FIGURE 40. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC THERAPY, 2018-2030 (USD MILLION)
FIGURE 41. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY INSTILLATION RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 42. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2030 (USD MILLION)
FIGURE 43. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY HIGH-DOSE-RATE BRACHYTHERAPY, 2018-2030 (USD MILLION)
FIGURE 44. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY LOW-DOSE-RATE BRACHYTHERAPY, 2018-2030 (USD MILLION)
FIGURE 45. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PULSED-DOSE-RATE BRACHYTHERAPY, 2018-2030 (USD MILLION)
FIGURE 46. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY INTRAVENOUS RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 47. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY ORAL RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 48. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 49. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 50. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 51. NORTH AMERICA RADIOTHERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 52. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
FIGURE 53. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY CERVICAL CANCER, 2018-2030 (USD MILLION)
FIGURE 54. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY COLORECTAL CANCER, 2018-2030 (USD MILLION)
FIGURE 55. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
FIGURE 56. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY HEAD & NECK CANCER, 2018-2030 (USD MILLION)
FIGURE 57. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY LUNG CANCER, 2018-2030 (USD MILLION)
FIGURE 58. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PENILE CANCER, 2018-2030 (USD MILLION)
FIGURE 59. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
FIGURE 60. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 61. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 62. NORTH AMERICA RADIOTHERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
FIGURE 63. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
FIGURE 64. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, 2018-2030 (USD MILLION)
FIGURE 65. CANADA RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 66. MEXICO RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 67. UNITED STATES RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 68. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 69. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 70. UNITED STATES RADIOTHERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 71. NORTH AMERICA RADIOTHERAPY MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 72. NORTH AMERICA RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 73. NORTH AMERICA RADIOTHERAPY MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022

List of Tables

TABLE 1. NORTH AMERICA RADIOTHERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. NORTH AMERICA RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 5. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL COBALT-60 TELETHERAPY UNITS, 2018-2030 (USD MILLION)
TABLE 7. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL COBALT-60 TELETHERAPY UNITS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 8. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
TABLE 9. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL LINEAR ACCELERATORS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 10. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY ELECTRON-EMITTING HIGH-ENERGY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
TABLE 11. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY ELECTRON-EMITTING HIGH-ENERGY LINEAR ACCELERATORS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 12. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 13. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 14. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 15. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 16. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 17. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY AFTERLOADERS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 18. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY APPLICATORS, 2018-2030 (USD MILLION)
TABLE 19. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY APPLICATORS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 20. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY IORT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 21. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY IORT SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 23. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY CYCLOTRONS, 2018-2030 (USD MILLION)
TABLE 25. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY CYCLOTRONS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY SYNCHROCYCLOTRON, 2018-2030 (USD MILLION)
TABLE 27. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY SYNCHROCYCLOTRON, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY SYNCHROTRONS, 2018-2030 (USD MILLION)
TABLE 29. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY SYNCHROTRONS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC ADVANCED ELECTRON OR COBALT-60 LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
TABLE 31. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC ADVANCED ELECTRON OR COBALT-60 LINEAR ACCELERATORS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY CYBERKNIFE, 2018-2030 (USD MILLION)
TABLE 33. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY CYBERKNIFE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY GAMMA KNIFE, 2018-2030 (USD MILLION)
TABLE 35. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY GAMMA KNIFE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY TOMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 37. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY TOMOTHERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 39. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY IOBENGUANE (I-131), 2018-2030 (USD MILLION)
TABLE 41. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY IOBENGUANE (I-131), BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY RHENIUM-186, 2018-2030 (USD MILLION)
TABLE 43. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY RHENIUM-186, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY SAMARIUM-153, 2018-2030 (USD MILLION)
TABLE 45. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY SAMARIUM-153, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 47. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 48. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY 3D CONFORMAL RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 50. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY 3D CONFORMAL RADIOTHERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY IMAGE-GUIDED RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 52. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY IMAGE-GUIDED RADIOTHERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY INTENSITY-MODULATED RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 54. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY INTENSITY-MODULATED RADIOTHERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY, 2018-2030 (USD MILLION)
TABLE 56. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC THERAPY, 2018-2030 (USD MILLION)
TABLE 58. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC THERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY INSTILLATION RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 60. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY INSTILLATION RADIOTHERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 62. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY HIGH-DOSE-RATE BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 64. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY HIGH-DOSE-RATE BRACHYTHERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY LOW-DOSE-RATE BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 66. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY LOW-DOSE-RATE BRACHYTHERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PULSED-DOSE-RATE BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 68. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PULSED-DOSE-RATE BRACHYTHERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY INTRAVENOUS RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 70. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY INTRAVENOUS RADIOTHERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 71. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY ORAL RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 72. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY ORAL RADIOTHERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 74. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 75. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 77. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY CERVICAL CANCER, 2018-2030 (USD MILLION)
TABLE 79. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY CERVICAL CANCER, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 80. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY COLORECTAL CANCER, 2018-2030 (USD MILLION)
TABLE 81. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 83. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY HEAD & NECK CANCER, 2018-2030 (USD MILLION)
TABLE 85. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 87. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY LUNG CANCER, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PENILE CANCER, 2018-2030 (USD MILLION)
TABLE 89. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PENILE CANCER, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 90. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 91. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 92. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 94. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 95. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, 2018-2030 (USD MILLION)
TABLE 96. NORTH AMERICA RADIOTHERAPY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 97. CANADA RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 98. CANADA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. CANADA RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 100. CANADA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. CANADA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. MEXICO RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 103. MEXICO RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. MEXICO RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 105. MEXICO RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. MEXICO RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. NORTH AMERICA RADIOTHERAPY MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 114. NORTH AMERICA RADIOTHERAPY MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 115. NORTH AMERICA RADIOTHERAPY MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 116. NORTH AMERICA RADIOTHERAPY MARKET RANKING, BY KEY PLAYER, 2022
TABLE 117. NORTH AMERICA RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2022
TABLE 118. NORTH AMERICA RADIOTHERAPY MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 119. NORTH AMERICA RADIOTHERAPY MARKET MERGER & ACQUISITION
TABLE 120. NORTH AMERICA RADIOTHERAPY MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 121. NORTH AMERICA RADIOTHERAPY MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 122. NORTH AMERICA RADIOTHERAPY MARKET INVESTMENT & FUNDING
TABLE 123. NORTH AMERICA RADIOTHERAPY MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 124. NORTH AMERICA RADIOTHERAPY MARKET: LICENSE & PRICING

Companies Mentioned

Accuray Incorporated
Becton, Dickinson and Company
Elekta AB
General Electric Company
IBA Worldwide
IntraOp Medical, Inc.
Koninklijke Philips N.V.
Leo Cancer Care
Mevion Medical Systems
Panacea Medical Technologies Pvt. Ltd.
Qfix
Radiology Oncology Systems
Varian Medical Systems, Inc.
ViewRay Technologies, Inc.
ZEISS Group

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.